proadifen has been researched along with Hyperglycemia in 2 studies
Proadifen: An inhibitor of drug metabolism and CYTOCHROME P-450 ENZYME SYSTEM activity.
Hyperglycemia: Abnormally high BLOOD GLUCOSE level.
Excerpt | Relevance | Reference |
---|---|---|
"ICRF-187, (+)-1,2-bis(3,5-dioxopiperazine-1-yl)propane, has been shown to protect against alloxan diabetes (el-Hage et al." | 3.67 | Mechanism of the protective activity of ICRF-187 against alloxan-induced diabetes in mice. ( Crouch, RK; el-Hage, A; Ferrans, VJ; Herman, EH; Yang, GC, 1986) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Wade, AE | 1 |
el-Hage, A | 1 |
Herman, EH | 1 |
Yang, GC | 1 |
Crouch, RK | 1 |
Ferrans, VJ | 1 |
2 other studies available for proadifen and Hyperglycemia
Article | Year |
---|---|
Atropine antagonism of carbachol-induced hyperglycemia.
Topics: Animals; Atropine; Carbachol; Dogs; Drug Antagonism; Female; Hyperglycemia; Male; Proadifen; Rabbits | 1967 |
Mechanism of the protective activity of ICRF-187 against alloxan-induced diabetes in mice.
Topics: Alloxan; Animals; Blood Glucose; Chelating Agents; Cimetidine; Diabetes Mellitus, Experimental; Dime | 1986 |